Funding · Company
Garuda Therapeutics, Inc.
Cambridge, MABiotech & Pharma
Garuda Therapeutics, Inc. of Cambridge, MA has disclosed $158M across 3 Form D offerings filed with the SEC between Sep 24, 2021 and Oct 31, 2024.
$158M
Total disclosed
3
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$62M
Form D · Feb 3, 2023 ↗
Q1 2023
· target $63M
$48M
Form D · Sep 24, 2021 ↗
Q3 2021
· target $72M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001884363Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →